Biotech · Private company
Abbisko Therapeutics Co, Ltd
Track this companyFree. Adds Abbisko Therapeutics Co, Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials65 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Pimicotinib(ABSK021)Phase 3 · Tenosynovial Giant Cell TumorClinicalTrials.gov · fetched Nov 12, 2026
- ABSK-011Phase 1 · Advanced Liver CancerClinicalTrials.gov · fetched Nov 12, 2026
- ABSK021Phase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- ABSK061Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- ABSK112Phase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- ABSK121-NXPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Feb 22, 2024ClinicalTrials.gov NCT06225804 · fetched Nov 12, 2026
- A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Jun 26, 2023ClinicalTrials.gov NCT05627063 · fetched Nov 12, 2026
- Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)PHASE3 · ACTIVE_NOT_RECRUITING · started Apr 27, 2023ClinicalTrials.gov NCT05804045 · fetched Nov 12, 2026
- A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid TumorsPHASE1 · UNKNOWN · started Jun 30, 2022ClinicalTrials.gov NCT05244551 · fetched Nov 12, 2026
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid TumorPHASE1 · RECRUITING · started Feb 26, 2020ClinicalTrials.gov NCT04906434 · fetched Nov 12, 2026
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid TumorPHASE1 · RECRUITING · started Jan 20, 2020ClinicalTrials.gov NCT04192344 · fetched Nov 12, 2026